
International Journal of Peptide and Protein Research p. 323 - 329 (1976)
Update date:2022-07-29
Topics:
Channabasavaiah
Sivanandaiah
Human fibrinopeptide A, a hexadecapeptide, released by the action of thrombin on fibrinogen during clotting of blood, has been synthesized by conventional methods. The synthetic peptide as well as some of the intermediates in the synthesis have been examined for anticoagulant activity. Though all of them were found to be active, the terminal carboxyl protected peptides are more potent inhibitors of clotting than the carboxyl free peptides.
shijiazhuang baisheng chem co.; ltd
Contact:86-0311-80790826
Address:shijiazhuang hebei
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
Contact:+86-571-86491666
Address:SHI XIANG ROAD
Shanghai Run-Biotech Co., Ltd.
website:http://www.run-biotech.com
Contact:+86-21-31576854/57171705 / 57171706
Address:second floor, building 3, No.999, jiangyue Road, minghang District, Shanghai, China
Doi:10.1016/S0968-0896(03)00159-7
(2003)Doi:10.1021/ja00806a031
(1973)Doi:10.1021/jo035329s
(2004)Doi:10.1039/P19730001615
(1973)Doi:10.1021/acs.orglett.0c02287
(2020)Doi:10.1002/hlca.19510340652
(1951)